ニュース

PipelineReview.com1 日
ArkBio Announces Positive Phase II Results of AK3280 for Treatment of Idiopathic Pulmonary ...
SHANGHAI, China I May 15, 2025 I Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced positive top-line Phase II study results for ...